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KEY POINTS
 Most nonpolypoid colorectal neoplasms (NP-CRNs) are visible, and their detection can be
facilitated by the use of chromoendoscopy.
 Chromoendoscopy using indigo carmine, in turn, also augments our further evaluation of
the border and pit pattern of the lesion.
 Magnifying endoscopy can assist us to further visualize the surface pattern, although
chronic inflammation and its sequela in patients with inflammatory bowel disease (IBD)
make the use of the pit pattern analysis less useful.
 In Japan, at present, efforts are given to clarify the merit for random biopsy.
 A nationwide randomized controlled trial is ongoing to clarify whether target biopsy or
random step biopsy is effective for the detection of NP-CRN.INTRODUCTION
Patients with inflammatory bowel disease (IBD) have a high risk of colitis-associated
dysplasia and cancer.1,2 These types of dysplasia and cancer, as compared with spo-
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Oka et al406multifocal, or anaplastic.3–7 Therefore, it is important that careful surveillance with co-
lonoscopy is performed for all patients with IBD and, more frequently, for those
considered to be at high risk.8–12 Traditionally, flat dysplasia in ulcerative colitis (UC)
has been considered to be detectable only by using random biopsy specimens of mu-
cosa that appeared unremarkable during endoscopy.13–15 However, recent studies
have shown that most of them are visible; thus, their detection as nonpolypoid colo-
rectal neoplasms (NP-CRNs) is an integral component in the prevention of colitic
cancer.9,16–18
Unlike dysplasia-associated lesions or masses, which are readily visible using con-
ventional endoscopy,19 the detection of NP-CRN can bemore difficult. NP-CRN in col-
itic IBD (cIBD) is often present simply as redness or a granular patch of mucosa that
may not be readily distinguishable from the surrounding inflamed mucosa. Because it
is often difficult to identify NP-CRN in cIBD using white light endoscopy, random blind
biopsies are still commonly practiced, especially in Western countries, to potentially
help detect these lesions. An alternative to random biopsy is to enhance the appear-
ance of NP-CRN by using image-enhanced endoscopy and, in turn, to target the
biopsy on areas that appear abnormal.
Several recent trials have evaluated dye-based image enhanced endoscopy (chro-
moendoscopy),20–28 magnifying endoscopy,16,29–33 and equipment-based image-
enhanced endoscopy (IEE)34–45 to detect NP-CRN in cIBD. Of these techniques,
the indigo carmine dye spray IEE has been shown to effectively increase the detec-
tion of areas suspected to contain NP-CRN and to delineate the border and surface
of suspected and obvious lesions.46 Equipment-based IEE is a promising, but un-
proven, method that is designed to visualize small vessels and minute mucosal pat-
terns. Of the currently available equipment-based IEE: narrow band imaging [NBI;
Olympus, Tokyo, Japan], flexible spectral imaging color enhancement [Fujifilm,
Tokyo, Japan], blue laser image [Fujifilm, Tokyo, Japan], autofluorescence imaging
[AFI; Olympus, Tokyo, Japan], and i-scan [Pentax, Tokyo, Japan], clinical trials on
the diagnosis of NP-CRN in cIBD have been published only for NBI and AFI.34–45
In this article, the authors describe the present status of the use of IEE to diagnose
NP-CRN using magnifying colonoscope and illustrate their practice at the Hiroshima
University Hospital. The authors have collated a few cases to provide examples of
their practice. The authors do not reiterate data reporting on the utility of chromoendo-
scopy as Subramanian and Bisschops have summarized them.THE PREVALENCE OF NP-CRN IN PATIENTS WITH IBD
Data show that nonpolypoid colorectal lesions are common in patients with IBD.
The true prevalence of NP-CRN in UC is difficult to estimate with the present endo-
scopic modality. Several studies provide a general estimate. Sada and colleagues16
reported that with surveillance colonoscopy in 1115 patients with UC, 39 colitic
dysplasias or cancers in 31 patients were detected; 30% of dysplasias (6 of 20)
were flat, and 16% of cancers (3 of 19) were depressed lesions. Toruner and col-
leagues17 reported that among 635 patients with IBD, 36 dysplasias were detected;
24 (67%) were nonpolypoid and 12 (33%) were polypoid. Rutter and colleagues18
reported that 77% of 110 colitic dysplasias or cancers in 525 patients with UC
were detected endoscopically, with 23% being flat. In an investigation by the Jap-
anese Ministry of Health, Labor, and Welfare, 42 lesions (79%) were polypoid and
11 lesions (21%) were nonpolypoid. Other reports have shown that more NP-CRN
were detected and diagnosed using magnifying endoscopy as compared with
chromoendoscopy.16,28–33
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The recent use of high-definition endoscopy with chromoendoscopy has enabled
endoscopists to directly visualize, localize, and diagnose NP-CRN in patients with
UC (see Table 1). Indigo carmine solution enhances the visualization of the border
and surface topography of the lesion to improve contrast compared with the surround-
ing mucosa in patients with UC.46 A meta-analysis has demonstrated that chromoen-
doscopy has medium to high sensitivity (83.3%, 95% confidence interval [CI]: 35.9–
99.6), specificity (91.3%, 95% CI: 43.8–100), and high diagnostic accuracy (odds ratio
17.544, 95% CI: 1.245–247.14) for dysplastic lesions47 and is superior to white light
colonoscopy for the proportion of lesions detected by biopsies (44%, 95% CI:
28.6–59.1) as well as for flat dysplasia (27%, 95% CI: 11.2–41.9) in patients with UC.26
Kiesslich and colleagues20 reported 165 patients with long-standing UC who were
randomized to conventional colonoscopy or colonoscopy with chromoendoscopy us-
ing 0.1% methylene blue. More targeted biopsies were possible, and significant intra-
epithelial neoplasia was detected in the chromoendoscopy group (32 vs 10; P5 .003).
Rutter and colleagues23 reported the importance of indigo carmine dye spraying for
the detection of dysplasia in UC. They emphasized that no dysplasia was detected
in 2904 nontargeted biopsies. In comparison, chromoendoscopy with targeted biopsy
led to fewer biopsies and detected 9 dysplastic lesions, 7 of which were only visible
after indigo carmine application. They concluded that the indigo carmine dye spraying
of the whole colon is feasible, and dysplasia detection may be more effective than tak-
ing large numbers of random biopsies. Hurlstone and colleagues31 also emphasized
that indigo carmine–assisted high-magnification chromoendoscopy and improved
the detection of intraepithelial neoplasia in the endoscopic screening of patients
with UC.
However, pancolonic chromoendoscopy has potential limitations: dye on the mu-
cosa is not always equally spread; dye pooling can lead to difficult observation;
more time is needed; and some biopsies may be false negative.
In the authors’ institution, they routinely perform high-magnification colonoscopy
with indigo carmine chromoendoscopy after they suspect the presence of NP-CRN
in patients with cIBD. Morphologically, NP-CRN in IBD appear to be slightly elevated,
completely flat, or slightly depressed as compared with the surrounding mucosa. In
order to detect them, the authors look for the presence of a slightly elevated lesion,
focal friability, obscure vascular pattern, discoloration (uneven redness or a patch or
redness), villous mucosa (velvety appearance), and irregular nodularity. The finding
of any of these signs typically alerts the authors to become suspicious of the possible
presence of NP-CRN and leads them to wash out the mucus or debris from the surface
on the target lesion and apply the dye for magnifying colonoscopy.15
MAGNIFYING COLONOSCOPY USING DYE SPRAYING FOR NP-CRN
After dye spraying but before the authors perform a biopsy or resection, they will typi-
cally evaluate the border of the lesion. The authors look for the presence of dye pooling
within the lesion, which would suggest the diagnosis of a depressed lesions. The au-
thors study the pit pattern of the mucosal surface.15 The authors’ experience and
others’, however, suggest that the current pit pattern classification may not be
completely applicable in UC, because the pit pattern of the regenerative hyperplastic
villous mucosa in UC (with the pits becoming elongated and irregular, depending on
the degree of inflammation) is difficult to distinguish from neoplastic pit patterns.
Instead of using the current pit pattern classification,48 the authors have previously re-
ported that high residual density of pits and irregular pit margins with magnification
Table 1
Studies on the use of chromoendoscopy in IBD
Author,
Published Year
No. of
Patients Study Design Setting
Dye
(%)
Endoscopy
Compared Indication Main Outcomes
Statistics:
P Value for
Comparison
Kiesslich
et al,20 2003
165 Parallel randomized trial UC surveillance MB 0.1 WLE Dysplasia detection True-positive lesions,
CE 32 vs WLE 10
.00315
Matsumoto
et al,21 2003
57 Prospective study UC surveillance IC 0.2 WLE Dysplasia detection Sensitivity, CE 86%
vs WLE 38%
NS
Rutter
et al,23 2004
100 Prospective study UC surveillance IC 0.1 WLE Dysplasia detection True-positive lesions,
CE 9 vs WLE 2
.06
Hurlstone
et al,31 2005
81 Prospective study UC surveillance IC 0.5 WLE Dysplasia detection True-positive lesions,
CE 69 vs WLE 24
<.0001
Kiesslich
et al,9 2007
153 Parallel randomized trial UC surveillance MB 0.1 WLE Dysplasia detection True-positive lesions,
CE 19 vs WLE 4
.005
Marion
et al,25 2008
102 Cross-sectional study IBD surveillance MB 0.1 WLE Dysplasia detection True-positive patients,
CE 17 vs WLE 3
.001
Gu¨nther
et al,27 2011
150 Parallel randomized trial IBD surveillance IC 0.1 WLE Dysplasia detection True-positive patients,
CE 6 vs WLE 0
<.05
Abbreviations: CE, chromoendoscopy; IC, indigo carmine; MB, methylene blue; NS, not significant; WLE, white light endoscopy.
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Nonpolypoid Colorectal Neoplasia in IBD 409after indigo carmine dye spraying were useful to differentiate between colitis-
associated neoplastic and non-neoplastic lesions.33 Therefore, in the authors’ prac-
tice, they focus on the high residual density of pits and irregular pit margins observed
under magnifying chromocolonoscopy.33
The main pit patterns of neoplasia in cIBD have been reported as type IV and type
IIIS with a IIIL pit pattern. Sada and colleagues
16 described that magnifying colonos-
copy of 15 neoplasias and showed that the patterns being type IIIS- to IIIL or type IV
pit. Hata and colleagues30 reported that they found no neoplastic lesions in regions
characterized by type II or I pit patterns. However, they also noted that some
non-neoplastic flat lesions also have type III and IV pit patterns, which are neoplastic
patterns. After completion of the characterization of the lesion, the authors perform the
biopsy or remove the lesion.DETECTION OF NP-CRN USING EQUIPMENT-BASED IEE
NBI
NBI is commonly used for the management of colorectal lesions in Japan. A large
body of the literature has reported on the utility of NBI for the detection of colorectal
polyps49–54 and for differentiating the diagnosis between neoplastic and non-
neoplastic lesions.49,55–61 Conversely, some studies have suggested that NBI magni-
fication is not effective for the detection of colorectal neoplasia.62–66 An advantage of
NBI magnification is that it can be achieved without spraying dye, thus potentially
reducing the cost. Because NBI involves a simple one-touch operation, NBI magnifi-
cation may shorten the procedure time required for diagnosing NP-CRN in IBD and
make the surveillance colonoscopy efficient. The major limitation of NBI, however, is
that the visual field becomes too dark during its application. A newer generation of
NBI has, therefore, been developed with improved brightness, although prospective
trials have not been performed.
In the previous clinical research on the significance of NBI endoscopy in detecting
NP-CRN in patients with UC, surveillance colonoscopy using NBI was associated with
negative results34–37; no significant difference in the ability to detect NP-CRN was
found between NBI and white light endoscopy (Table 2). Dekker and colleagues35 re-
ported that 52 visible lesions were identified in 17 patients during NBI endoscopy
compared with 28 visible lesions identified in patients using white light endoscopy.
A pathologic evaluation of target biopsies showed 11 patients with neoplasia, which
was detected by both techniques in 4 patients, whereas only 4 cases were detected
using NBI endoscopy alone and 3 cases using white light endoscopy. Van den Broek
and colleagues38 also reported that 11 of 16 (69%) neoplastic lesions were detected
by white light, whereas NBI endoscopy detected 13 of 16 (81%) cases (nonsignificant
differences). Efthymiou and colleagues42 reported that when using chromoendo-
scopy, 131 lesions (92%) were detected as compared with 102 lesions (70%) with
NBI (P<.001); the median number of lesions detected per patient was 3 with chro-
moendoscopy and 1.5 with NBI (P 5 .002).
NBI magnification, however, was not used in these clinical studies. The authors,
thus, have continued to study the use of magnifying endoscopy with NBI in their
unit in Hiroshima (Figs. 1–3). The authors think that it is possible that the reported re-
sults in the literature were negative because of the difficulty to accurately discriminate
between active inflammation and neoplasia. The authors also studied other potential
advantages of the use of NBI magnification. Bisschops and colleagues40 reported that
the withdrawal time for NBI was significantly shorter than that of CE, although NBI
endoscopy and CE showed equivalent dysplasia detection rates. Pellise´ and
Table 2
Studies on the use of image-enhanced endoscopy in IBD
Author,
Published Year
No. of
Patients Study Design Setting IEE
Endoscopy
Compared Indication Main Outcomes
Statistics:
P Value for
Comparison
Dekker
et al,35 2007
42 Randomized
crossover trial
UC surveillance NBI WLE Dysplasia
detection
Suspicious lesions, NBI 52 vs WLE 28 .026
True-positive lesions, NBI 9 vs WLE 12 .672
False-positive lesions, NBI 43 vs WLE 16 .015
Matsumoto
et al,36 2007
46 Cross-sectional
study
UC surveillance NBI WLE Dysplasia
differentiation
Positive rate of dysplasia, tortuous
pattern (4/50 sites, 8%) vs
honeycomblike or villous patterns
(1/246 sites, 0.4%)
.003
Van den Broek
et al,44 2008
50 Randomized
crossover trial
UC surveillance AFI WLE Dysplasia
detection
Neoplasia miss rates, AFI 0% vs and
WLE 50%
.036
NBI AFI Dysplasia
differentiation
AFI (sensitivity 100%) vs NBI (sensitivity
75%, specificity 81%)
Matsumoto
et al,43 2010
48 Prospective
study
UC surveillance AFI WLE Dysplasia
detection
Positive rate of dysplasia, protrusions
(30%) vs flat mucosa (3.3%)
<.0001
Positive rate of dysplasia in flat lesions,
low AF (8.2%) vs high AFI (0%)
.3
Pellise
et al,37 2011
60 Randomized
crossover trial
UC surveillance NBI WLE with
indigo
carmine
Dysplasia
detection
Suspicious lesions, NBI 136 vs WLE 208 .001
True-positive lesions, NBI 10 vs WLE 12 .644
False-positive lesions, NBI 126 vs WLI 196 .001
van den Broek
et al,38 2011
48 Randomized
crossover trial
IBD surveillance NBI WLE Dysplasia
detection
True-positive lesions, NBI 13 vs WLE 11 .727
Ignjatovic
et al,41 2012
112 Parallel
randomized
trial
UC surveillance NBI WLE Dysplasia
detection
True-positive lesions, NBI 5 vs WLE 7 .57
False-positive lesions, NBI 12 vs WLI 4 .06
Efthymiou
et al,42 2013
144 Randomized
crossover trial
UC surveillance NBI WLE Dysplasia
detection
Suspicious lesions, NBI 102 vs WLE 131 <.001
True-positive lesions, NBI 20 vs WLE 23 .18
Abbreviation: WLE, white light endoscopy.
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Fig. 1. A 53-year-old woman, 10 years after the onset of UC. (A) Ordinary colonoscopic view.
A flat elevated lesion was noted in the rectum. (B) NBI showed the slightly elevated lesion
with mucus present. (C) High-magnification imaging with NBI revealed the irregular surface
pattern. (D) View with indigo carmine dye spraying. The focal lesion that is not covered with
the indigo carmine solution is unclear. Proctocolectomy was performed. (E) Cross section of
the specimen (hematoxylin-eosin). (F) The lesion was diagnosed histologically as intramu-
cosal well-differentiated adenocarcinoma.
Fig. 2. A 35-year-old man, 21 years after the onset of UC. (A) Ordinary colonoscopic view.
The reddened flat lesion was identified. (B) NBI showed the flat lesion as a brownish
area. (C) High-magnification imaging with NBI revealed the irregular surface pattern and
microvessels. (D) View with indigo carmine dye spraying. A 0-IIa1IIc lesion was clearly delin-
eated. Proctocolectomy was performed. (E) The lesion was diagnosed histologically as sub-
mucosal invasive well-differentiated adenocarcinoma.
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Fig. 3. A 47-year-old woman, 5 years after the onset of UC. (A) Ordinary colonoscopic view.
A whitish flat elevated lesion was noted in the rectum. (B) NBI showed the slightly elevated
lesion. (C) High-magnification imaging with NBI revealed the mild irregular surface pattern.
(D) View with indigo carmine dye spraying. The focal lesion was relatively clear. Endoscopic
submucosal dissection was performed on the lesion. (E) Cross section of the specimen (hema-
toxylin-eosin). (F) The lesion was diagnosed histologically as low-grade dysplasia.
Oka et al412colleagues37 reported that NBI endoscopy had a significantly inferior false-positive bi-
opsy rate and a similar true-positive rate compared with CE. It has been reported that
the magnified observation of UC using NBI is useful to discriminate between
dysplastic/neoplastic and non-neoplastic lesions and to guide for the necessity of per-
forming a target biopsy. East and colleagues found that dysplasias were seen as
darker capillary vascular patterns. Matsumoto and colleagues36 reported that the
tortuous pattern of capillaries determined by NBI endoscopy might be a clue for the
identification of dysplasia during surveillance colonoscopy for patients with UC.
The authors have previously reported the clinical usefulness of NBI magnification for
the qualitative diagnosis of sporadic colorectal lesions by the combined evaluation
of both surface pattern and microvessel features.55 The surface pattern is thought
to be more useful for endoscopic findings because inflammation causes the structure
of microvessel features to become disordered.
AFI
AFI is a novel technique that uses a short-wavelength light to excite endogenous tis-
sue fluorophores that emit fluorescent light of longer wavelength. AFI highlights
neoplastic tissue without the administration of exogenous fluorophores as described
earlier in UC.43–45 AFI images of UC lesions can be classified into 4 categories: green,
green with purple spots, purple with green spots, and purple. The strength of the pur-
ple staining in AFI images of UC lesions is related to the histologic severity. Using AFI,
colitis-associated neoplasias are observed as a purple area, regardless of their
macroscopic types.43–45
AFI endoscopy has been reported to be promising for the detection of dysplasia in
UC,43–45 although the clinical potential of AFI in routine colonoscopy has been compli-
cated by high false-positive detection rates, particularly in cases of NP-CRN (see
Nonpolypoid Colorectal Neoplasia in IBD 413Table 2). Van den Broek and colleagues44 reported that AFI endoscopy improves the
diagnosis of dysplasia in patients with UC. However, the interpretation of the results
should be done with caution because the study initially excluded patients with active
inflammation. Because AFI is attenuated in colonic inflammation as well as in
neoplasm, such exclusion seems to have contributed positively to the assessment
of AFI endoscopy by decreasing the number of false-positive areas. Matsumoto
and colleagues45 reported that AFI endoscopy identified 14 dysplasias in 4 patients
during surveillance colonoscopy of 48 patients with UC. Eleven lesions were polypoid
lesions, and the other 3 lesions were flat lesions. Autofluorescence as determined by
AFI was regarded to be low in 12 lesions and to be normal in 2 lesions. Thus, the spec-
ificity of AFI endoscopy for the detection of flat dysplasia was, in fact, less than those
of the prior investigations by NBI endoscopy or chromoendoscopy.44,45 This finding
seems to be a consequence of patchy inflammation in the observed area because
autofluorescence under AFI endoscopy was altered according to the grade of inflam-
mation in patients with UC. In order to use AFI for surveillance colonoscopy in patients
with UC, it is necessary to express autofluorescence numerically and objectively and
to clarify the discrimination between the inflammation and neoplastic lesions. There
have not been any large trials on the usefulness of AFI for the detection of colitis-
associated dysplasia and cancer. AFI may have great potential for the detection of
non–polypoid colitis–associated dysplasia and cancer without magnification.SUMMARY
Most NP-CRNs are visible, and their detection can be facilitated by the use of chro-
moendoscopy. Chromoendoscopy using indigo carmine, in turn, also augments the
further evaluation of the border and surface pattern of the lesion. Magnifying endos-
copy can assist in further visualizing the surface pattern, although chronic inflamma-
tion and its sequela in patients with IBD make the use of the pit pattern analysis less
useful. In Japan, at present, efforts are given to clarify the merit for random biopsy. A
nationwide randomized controlled trial is ongoing to clarify whether target biopsy or
random step biopsy is effective for the detection of NP-CRN.67REFERENCES
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